These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 6546902

  • 1. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
    Bush LR, Campbell WB, Buja LM, Tilton GD, Willerson JT.
    Circulation; 1984 Jun; 69(6):1161-70. PubMed ID: 6546902
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
    Bush LR, Campbell WB, Kern K, Tilton GD, Apprill P, Ashton J, Schmitz J, Buja LM, Willerson JT.
    Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
    [Abstract] [Full Text] [Related]

  • 4. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.
    Schmitz JM, Apprill PG, Buja LM, Willerson JT, Campbell WB.
    Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
    Ashton JH, Schmitz JM, Campbell WB, Ogletree ML, Raheja S, Taylor AL, Fitzgerald C, Buja LM, Willerson JT.
    Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
    [Abstract] [Full Text] [Related]

  • 6. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P, Rosolowsky M, Yao SK, McNatt J, De Clerck F, Buja LM, Willerson JT.
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [Abstract] [Full Text] [Related]

  • 7. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
    Schumacher WA, Lucchesi BR.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
    [Abstract] [Full Text] [Related]

  • 8. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.
    Ashton JH, Ogletree ML, Michel IM, Golino P, McNatt JM, Taylor AL, Raheja S, Schmitz J, Buja LM, Campbell WB.
    Circulation; 1987 Oct; 76(4):952-9. PubMed ID: 3652429
    [Abstract] [Full Text] [Related]

  • 9. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P, Ambrosio G, Villari B, Ragni M, Focaccio A, Pace L, de Clerk F, Condorelli M, Chiariello M.
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [Abstract] [Full Text] [Related]

  • 10. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK, Ober JC, McNatt J, Benedict CR, Rosolowsky M, Anderson HV, Cui K, Maffrand JP, Campbell WB, Buja LM.
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [Abstract] [Full Text] [Related]

  • 11. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J, Thaulow E, Myhre E, Parry J.
    Thromb Haemost; 1983 Oct 31; 50(3):703-6. PubMed ID: 6689091
    [Abstract] [Full Text] [Related]

  • 12. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
    Yao SK, Rosolowsky M, Anderson HV, Golino P, NcNatt JM, De Clerck F, Buja LM, Willerson JT.
    J Am Coll Cardiol; 1990 Sep 31; 16(3):705-13. PubMed ID: 2143767
    [Abstract] [Full Text] [Related]

  • 13. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
    Yao SK, Benedict CR, Rosolowsky M, McNatt J, Falinska B, Campbell WB, Buja LM, Willerson JT.
    J Mol Cell Cardiol; 1991 Apr 31; 23(4):473-82. PubMed ID: 1942081
    [Abstract] [Full Text] [Related]

  • 14. The thromboxane A2 mimetic U46619 worsens canine myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis.
    Bache RJ, Dai XZ.
    Cardiovasc Res; 1992 Apr 31; 26(4):351-6. PubMed ID: 1638566
    [Abstract] [Full Text] [Related]

  • 15. Effects of Y-20811, a thromboxane A2 synthetase inhibitor, on experimentally induced coronary thrombosis in anesthetized dogs.
    Matsumoto Y, Ochi H, Aihara K, Inui J, Ikegami K.
    Eur J Pharmacol; 1992 Mar 24; 213(2):167-70. PubMed ID: 1521557
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo.
    Golino P, Buja LM, Yao SK, McNatt J, Willerson JT.
    J Am Coll Cardiol; 1990 Mar 01; 15(3):718-26. PubMed ID: 2105989
    [Abstract] [Full Text] [Related]

  • 18. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
    Willerson JT, Igo SR, Yao SK, Ober JC, Macris MP, Ferguson JJ.
    Tex Heart Inst J; 1996 Mar 01; 23(1):1-8. PubMed ID: 8680268
    [Abstract] [Full Text] [Related]

  • 19. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
    Bureau MF, De Clerck F, Lefort J, Arreto CD, Vargaftig BB.
    J Pharmacol Exp Ther; 1992 Feb 01; 260(2):832-40. PubMed ID: 1738127
    [Abstract] [Full Text] [Related]

  • 20. Neuropeptide Y and coronary vasoconstriction: role of thromboxane A2.
    Martin SE, Kuvin JT, Offenbacher S, Odle BM, Patterson RE.
    Am J Physiol; 1992 Oct 01; 263(4 Pt 2):H1045-53. PubMed ID: 1415751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.